Brainsway Stock Performance
| BWAY Stock | USD 10.62 0.15 1.43% |
Brainsway has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.79, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Brainsway's returns are expected to increase less than the market. However, during the bear market, the loss of holding Brainsway is expected to be smaller as well. Brainsway right now shows a risk of 2.85%. Please confirm Brainsway coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to decide if Brainsway will be following its price patterns.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Brainsway are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Brainsway is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 47.6 M |
Brainsway |
Brainsway Relative Risk vs. Return Landscape
If you would invest 1,032 in Brainsway on November 2, 2024 and sell it today you would earn a total of 30.00 from holding Brainsway or generate 2.91% return on investment over 90 days. Brainsway is currently generating 0.0882% in daily expected returns and assumes 2.8526% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Brainsway, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Brainsway Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brainsway's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Brainsway, and traders can use it to determine the average amount a Brainsway's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0309
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | BWAY | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.85 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Brainsway is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Brainsway by adding it to a well-diversified portfolio.
Brainsway Fundamentals Growth
Brainsway Stock prices reflect investors' perceptions of the future prospects and financial health of Brainsway, and Brainsway fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Brainsway Stock performance.
| Return On Equity | 0.0144 | ||||
| Return On Asset | 0.0073 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 156.64 M | ||||
| Shares Outstanding | 18.82 M | ||||
| Price To Book | 4.47 X | ||||
| Price To Sales | 5.61 X | ||||
| Revenue | 31.79 M | ||||
| EBITDA | (2.31 M) | ||||
| Cash And Equivalents | 49.62 M | ||||
| Cash Per Share | 2.95 X | ||||
| Total Debt | 471 K | ||||
| Debt To Equity | 0.01 % | ||||
| Book Value Per Share | 1.25 X | ||||
| Cash Flow From Operations | 1.28 M | ||||
| Earnings Per Share | 0.08 X | ||||
| Total Asset | 62.97 M | ||||
| Retained Earnings | (101.3 M) | ||||
About Brainsway Performance
Evaluating Brainsway's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Brainsway has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Brainsway has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 118 people.Things to note about Brainsway performance evaluation
Checking the ongoing alerts about Brainsway for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Brainsway help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Brainsway has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 31.79 M. Net Loss for the year was (4.2 M) with profit before overhead, payroll, taxes, and interest of 27.26 M. |
- Analyzing Brainsway's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Brainsway's stock is overvalued or undervalued compared to its peers.
- Examining Brainsway's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Brainsway's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Brainsway's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Brainsway's stock. These opinions can provide insight into Brainsway's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Brainsway Stock Analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.